Status:

COMPLETED

Recognition of Heart Failure With Micro Electro-Mechanical Sensors (REFLECS)

Lead Sponsor:

Francois Haddad

Collaborating Sponsors:

Precordior Ltd

Conditions:

Heart Failure

Pulmonary Hypertension

Eligibility:

All Genders

21+ years

Brief Summary

The study will test the ability a novel wearable sensor based on a smartphone app (Precordior CardioSignal app) in combination with a sensor device (Suunto Movesense sensor) to non-invasively measure ...

Detailed Description

Heart Failure (HF) is a syndrome where the heart is unable to pump or fill adequately to meet the circulatory needs of the body. The main purpose of this study is to test the ability a novel wearable ...

Eligibility Criteria

Inclusion

  • Age ≥ 21 years
  • Able to consent in English and follow study instructions
  • Patients hospitalized or being seen in clinic with heart failure with a diagnosis of HFpEF, HFrEF or PH, as corresponding to each target patient group
  • Control patients may include patients that are hospitalized without heart failure, and cardiology patients without heart failure who are seen in outpatient cardiology, who may have suspected CAD and are scheduled for CCTA.

Exclusion

  • Severe cardiac valvular heart disease
  • Previous prosthetic cardiac valve
  • Pericardial disease including constrictive pericarditis or moderate or large pericardial effusion
  • Mechanical circulatory support (including ECMO, LVADs etc).
  • Heart and/or lung transplant recipients
  • Major adverse cardiovascular event or surgery within 6 weeks of planned study enrollment
  • Patients with pacemaker that has over 1% of beats paced
  • Pectus excavatum (severe)
  • Pregnant women
  • On Dialysis
  • Exclude at the clinical discretion of the Principal Investigators
  • Not possible to acquire echocardiography with sufficient quality

Key Trial Info

Start Date :

December 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 7 2023

Estimated Enrollment :

205 Patients enrolled

Trial Details

Trial ID

NCT04378179

Start Date

December 1 2020

End Date

October 7 2023

Last Update

December 2 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stanford University

Palo Alto, California, United States, 94305